Latest Articles

  • Exchanging the skin bleb for the test tube
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2010, 77 (9) 566; DOI: https://doi.org/10.3949/ccjm.77a.09001

    New blood tests are a positive step towards accurate recognition and treatment of patients with latent tuberculosis.

  • Timeliness of treatment is more important than choice of reperfusion therapy
    Eric R. Bates, MD
    Cleveland Clinic Journal of Medicine September 2010, 77 (9) 567-569; DOI: https://doi.org/10.3949/ccjm.77a.10085

    The most important modifiable predictor of outcome in ST-segment elevation MI is the time to treatment, a biological truth that continues to be supported by clinical evidence.

  • Combined reperfusion strategies in ST-segment elevation MI: Rationale and current role
    Elias B. Hanna, MD, Thomas A. Hennebry, MD and Mazen S. Abu-Fadel, MD
    Cleveland Clinic Journal of Medicine September 2010, 77 (9) 629-638; DOI: https://doi.org/10.3949/ccjm.77a.10024

    In geographic areas where percutaneous coronary intervention (PCI) is not immediately available, the best strategy may be to give thrombolysis immediately and then to transfer the patient to a PCI hospital.

  • Hepatitis C virus: Prevention, screening, and interpretation of assays
    Mazen Albeldawi, MD, Ernesto Ruiz-Rodriguez, MD and William D. Carey, MD
    Cleveland Clinic Journal of Medicine September 2010, 77 (9) 616-626; DOI: https://doi.org/10.3949/ccjm.77a.09162

    Patients at risk of hepatitis C virus infection should be screened for it so that they can be treated and potentially cured, or can at least avoid transmitting the disease to others.

  • Interferon-gamma-release assays: Better than tuberculin skin testing?
    Cyndee Miranda, MD, J. Walton Tomford, MD and Steven M. Gordon, MD
    Cleveland Clinic Journal of Medicine September 2010, 77 (9) 606-611; DOI: https://doi.org/10.3949/ccjm.77a.09112

    These new blood tests overcome some of the limitations of skin testing, but converting to them poses challenges.

  • Charcot neuroarthropathy: An often overlooked complication of diabetes
    Charcot neuroarthropathy: An often overlooked complication of diabetes
    Georgeanne Botek, DPM, Martha A. Anderson, DPM and Ryan Taylor, DPM
    Cleveland Clinic Journal of Medicine September 2010, 77 (9) 593-599; DOI: https://doi.org/10.3949/ccjm.77a.09163

    Suspect this condition if a patient with long-standing, poorly controlled diabetes and peripheral neuropathy develops a red, hot, swollen foot without ulceration.

  • Do incretin drugs for type 2 diabetes increase the risk of acute pancreatitis?
    Leann Olansky, MD
    Cleveland Clinic Journal of Medicine August 2010, 77 (8) 503-505; DOI: https://doi.org/10.3949/ccjm.77a.09167

    Probably not. The risk is higher in type 2 diabetes regardless of treatment.

  • A young woman with a breast mass: What every internist should know
    Robert Wesolowski, MD and George Thomas Budd, MD
    Cleveland Clinic Journal of Medicine August 2010, 77 (8) 537-546; DOI: https://doi.org/10.3949/ccjm.77a.09095

    What is the differential diagnosis? What workup is appropriate? And what is the next step?

  • HIV: Just another chronic disease
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine August 2010, 77 (8) 489; DOI: https://doi.org/10.3949/ccjm.77a.08001

    Did we ever expect a time when HIV would be viewed as a chronic disease, with patients warranting screening for coronary artery disease in order to decrease long-term coronary complications?

  • How to prevent glucocorticoid-induced osteoporosis
    Robin K. Dore, MD
    Cleveland Clinic Journal of Medicine August 2010, 77 (8) 529-536; DOI: https://doi.org/10.3949/ccjm.77a.10003

    When prescribing glucocorticoids for long-term treatment, physicians should take steps to prevent osteoporosis.

Pages